Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 The True Cost of Inadequate Extractables & Leachables Testing | Contract Pharma

What are you searching for?

Sign in
White Papers / Tech Papers

The True Cost of Inadequate Extractables & Leachables Testing

E&L assessments are vital to ensure patient safety and consistent product quality.

Released By Solvias

Abstract:

Extractables and Leachables (E&L) studies are critical analyses conducted when developing a pharmaceutical product. These studies assess the potential for chemical compounds to migrate from containers, closures, and other packaging into the drug product. Therefore, E&L assessments are vital to ensure patient safety and consistent product quality.

E&L studies are often under-appreciated in the drug development process. While a generic, one size fits all approach may provide a superficial understanding of potential chemical interactions, it frequently falls short in identifying all E&Ls.

In this white paper, we cover the risks and true cost of inadequate E&L testing.

Download White Papers / Tech Papers Now

Download White Papers / Tech Papers Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics